241 related articles for article (PubMed ID: 10578132)
1. Pharmacological characterization of the human P2Y11 receptor.
Communi D; Robaye B; Boeynaems JM
Br J Pharmacol; 1999 Nov; 128(6):1199-206. PubMed ID: 10578132
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of the human P2Y13 receptor.
Marteau F; Le Poul E; Communi D; Communi D; Labouret C; Savi P; Boeynaems JM; Gonzalez NS
Mol Pharmacol; 2003 Jul; 64(1):104-12. PubMed ID: 12815166
[TBL] [Abstract][Full Text] [Related]
3. Sp-2-propylthio-ATP-α-B and Sp-2-propylthio-ATP-α-B,β-γ-dichloromethylene are novel potent and specific agonists of the human P2Y₁₁ receptor.
Haas M; Ben-Moshe I; Fischer B; Reiser G
Biochem Pharmacol; 2013 Sep; 86(5):645-55. PubMed ID: 23810430
[TBL] [Abstract][Full Text] [Related]
4. Alanine-(87)-threonine polymorphism impairs signaling and internalization of the human P2Y11 receptor, when co-expressed with the P2Y1 receptor.
Haas M; Shaaban A; Reiser G
J Neurochem; 2014 May; 129(4):602-13. PubMed ID: 24524250
[TBL] [Abstract][Full Text] [Related]
5. Extracellular ATP has stimulatory effects on the expression and release of IL-6 via purinergic receptors in normal human epidermal keratinocytes.
Inoue K; Hosoi J; Denda M
J Invest Dermatol; 2007 Feb; 127(2):362-71. PubMed ID: 16946718
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological profile of a novel cyclic AMP-linked P2 receptor on undifferentiated HL-60 leukemia cells.
Conigrave AD; Lee JY; van der Weyden L; Jiang L; Ward P; Tasevski V; Luttrell BM; Morris MB
Br J Pharmacol; 1998 Aug; 124(7):1580-5. PubMed ID: 9723974
[TBL] [Abstract][Full Text] [Related]
7. Interaction of new, very potent non-nucleotide antagonists with Arg256 of the human platelet P2Y12 receptor.
Hoffmann K; Baqi Y; Morena MS; Glänzel M; Müller CE; von Kügelgen I
J Pharmacol Exp Ther; 2009 Nov; 331(2):648-55. PubMed ID: 19690189
[TBL] [Abstract][Full Text] [Related]
8. Phospholipase C and cAMP-dependent positive inotropic effects of ATP in mouse cardiomyocytes via P2Y11-like receptors.
Balogh J; Wihlborg AK; Isackson H; Joshi BV; Jacobson KA; Arner A; Erlinge D
J Mol Cell Cardiol; 2005 Aug; 39(2):223-30. PubMed ID: 15893764
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterisation of the P2Y11 receptor in stably transfected haematological cell lines.
van der Weyden L; Adams DJ; Luttrell BM; Conigrave AD; Morris MB
Mol Cell Biochem; 2000 Oct; 213(1-2):75-81. PubMed ID: 11129961
[TBL] [Abstract][Full Text] [Related]
10. Comparison of P2 receptor subtypes producing dilation in rat intracerebral arterioles.
Horiuchi T; Dietrich HH; Hongo K; Dacey RG
Stroke; 2003 Jun; 34(6):1473-8. PubMed ID: 12730558
[TBL] [Abstract][Full Text] [Related]
11. Adenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK 293 cells; involvement of the P2Y13 receptor-type.
Wirkner K; Schweigel J; Gerevich Z; Franke H; Allgaier C; Barsoumian EL; Draheim H; Illes P
Br J Pharmacol; 2004 Jan; 141(1):141-51. PubMed ID: 14662731
[TBL] [Abstract][Full Text] [Related]
12. Slow desensitization of the human P2Y6 receptor.
Robaye B; Boeynaems JM; Communi D
Eur J Pharmacol; 1997 Jun; 329(2-3):231-6. PubMed ID: 9226417
[TBL] [Abstract][Full Text] [Related]
13. Identification of competitive antagonists of the P2Y1 receptor.
Boyer JL; Romero-Avila T; Schachter JB; Harden TK
Mol Pharmacol; 1996 Nov; 50(5):1323-9. PubMed ID: 8913364
[TBL] [Abstract][Full Text] [Related]
14. Adenine triphosphate nucleotides are antagonists at the P2Y receptor.
Kauffenstein G; Hechler B; Cazenave JP; Gachet C
J Thromb Haemost; 2004 Nov; 2(11):1980-8. PubMed ID: 15550030
[TBL] [Abstract][Full Text] [Related]
15. The P2Y11 receptor mediates the ATP-induced maturation of human monocyte-derived dendritic cells.
Wilkin F; Duhant X; Bruyns C; Suarez-Huerta N; Boeynaems JM; Robaye B
J Immunol; 2001 Jun; 166(12):7172-7. PubMed ID: 11390464
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of the response to purinergic agonists in P2Y1 transfected 1321N1 cells by antagonists suramin and PPADS.
Brown CA; Charlton SJ; Boarder MR
Br J Pharmacol; 1997 Mar; 120(6):1049-52. PubMed ID: 9134216
[TBL] [Abstract][Full Text] [Related]
17. Effects of P2Y(1) and P2Y(12) receptor antagonists on ADP-induced shape change of equine platelets: comparison with human platelets.
Mateos-Trigos G; Evans RJ; Heath MF
Platelets; 2002; 13(5-6):285-92. PubMed ID: 12189014
[TBL] [Abstract][Full Text] [Related]
18. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C
Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a Ca2+ response to both UTP and ATP at human P2Y11 receptors: evidence for agonist-specific signaling.
White PJ; Webb TE; Boarder MR
Mol Pharmacol; 2003 Jun; 63(6):1356-63. PubMed ID: 12761346
[TBL] [Abstract][Full Text] [Related]
20. P2Y(AC)(-)-receptor agonists enhance the proliferation of rat C6 glioma cells through activation of the p42/44 mitogen-activated protein kinase.
Claes P; Grobben B; Van Kolen K; Roymans D; Slegers H
Br J Pharmacol; 2001 Sep; 134(2):402-8. PubMed ID: 11564659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
